Soleno Therapeutics files 8-K with corporate presentation; no specific results disclosed

SOLENO THERAPEUTICS INC

Presentation furnished under Regulation FD; no financial metrics or guidance provided in filing.
Company is a clinical-stage biotech focused on Prader-Willi syndrome; pipeline update likely in exhibit.
No material event such as earnings, M&A, or leadership change announced in this 8-K.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.